We are live on ! Find out more
ADAP

Adaptimmune Therapeutics

Delisted

ADAP was delisted on the 27th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
MCMC
1
Matrix Capital Management Company
New Hampshire
$80.3M
NMC
2
NEA Management Company
Maryland
$35.2M
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$31.7M +$4.38M +1,624,186 +12%
BBA
4
Baker Bros. Advisors
New York
$20.3M
LFCM
5
Long Focus Capital Management
Puerto Rico
$9.13M +$6.12M +2,267,178 +105%
SP
6
Syncona Portfolio
Guernsey
$5.17M
PHS
7
PFM Health Sciences
California
$4.89M -$2.23M -826,392 -26%
RSCM
8
Rock Springs Capital Management
Maryland
$4.73M +$220K +81,606 +4%
ECM
9
Endurant Capital Management
California
$4.45M +$3.41M +1,263,311 +141%
Morgan Stanley
10
Morgan Stanley
New York
$4.23M -$513K -190,038 -8%
Citadel Advisors
11
Citadel Advisors
Florida
$3.6M +$598K +221,412 +14%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$3.25M
Millennium Management
13
Millennium Management
New York
$2.98M -$529K -195,864 -12%
JP Morgan Chase
14
JP Morgan Chase
New York
$2.88M -$211K -78,273 -5%
BlackRock
15
BlackRock
New York
$2.74M +$432K +160,146 +14%
Renaissance Technologies
16
Renaissance Technologies
New York
$1.98M +$1.44M +532,016 +124%
State Street
17
State Street
Massachusetts
$1.32M +$69.2K +25,627 +4%
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$1.2M +$46.7K +17,300 +3%
Rafferty Asset Management
19
Rafferty Asset Management
New York
$1.1M -$191K -70,649 -12%
Bank of America
20
Bank of America
North Carolina
$1.08M -$37.5K -13,899 -3%
RG
21
Rathbones Group
United Kingdom
$892K
KCFA
22
Key Client Fiduciary Advisors
New Jersey
$866K +$444K +164,399 +64%
Goldman Sachs
23
Goldman Sachs
New York
$741K +$139K +51,408 +17%
DCM
24
DAFNA Capital Management
California
$723K +$580K +214,798 +158%
Two Sigma Investments
25
Two Sigma Investments
New York
$544K +$712K +263,960 New